CHATTANOOGA, Tenn. (WDEF) – The American Diabetes Association (ADA) is applauding TennCare for expanding coverage to include FDA-approved weight-management medications, including GLP-1 receptor agonists.
This decision comes at a critical time, as nearly 4 in 10 Tennessee adults live with obesity, putting them at increased risk for over 200 medical conditions, from type 2 diabetes to heart disease.
“GLP-1 medications offer the rare opportunity to better manage chronic conditions, improve health, reduce medical costs, and drive productivity,” said Gary Dougherty, the ADA’s Senior Director of State Government Affairs…